User profiles for C. N. Bernstein

Charles N Bernstein

Distinguished Professor of Medicine, University of Manitoba
Verified email at umanitoba.ca
Cited by 75272

Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

F Shanahan, WM Weinstein, CN Bernstein - The Lancet, 1994 - Elsevier
The recommended approach to the increased risk of colorectal carcinoma in ulcerative colitis
has been colonoscopic surveillance rather than prophylactic colectomy. This strategy is …

The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study

CN Bernstein, JF Blanchard… - Thrombosis and …, 2001 - thieme-connect.com
Background: There is an impression mostly from specialty clinics that patients with inflammatory
bowel disease (IBD) have an increased risk of venous thromboembolic disorders. Our …

Brain-gut interactions in inflammatory bowel disease

BL Bonaz, CN Bernstein - Gastroenterology, 2013 - Elsevier
Psycho-neuro-endocrine-immune modulation through the brain-gut axis likely has a key
role in the pathogenesis of inflammatory bowel disease (IBD). The brain-gut axis involves …

Diversity of the human intestinal microbial flora

PB Eckburg, EM Bik, CN Bernstein, E Purdom… - science, 2005 - science.org
The human endogenous intestinal microflora is an essential “organ” in providing nourishment,
regulating epithelial development, and instructing innate immunity; yet, surprisingly, basic …

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress …

…, T Ahmad, IDR Arnott, CN Bernstein… - Canadian Journal of …, 2005 - hindawi.com
The discovery of a series of genetic and serological markers associated with disease
susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an …

[HTML][HTML] Infliximab maintenance therapy for fistulizing Crohn's disease

BE Sands, FH Anderson, CN Bernstein… - … England Journal of …, 2004 - Mass Medical Soc
Background Infliximab, a monoclonal antibody against tumor necrosis factor, is an effective
maintenance therapy for patients with Crohn's disease without fistulas. It is not known …

Cancer risk in patients with inflammatory bowel disease: a population‐based study

CN Bernstein, JF Blanchard, E Kliewer, A Wajda - Cancer, 2001 - Wiley Online Library
BACKGROUND The objective of the current study was to determine the incidence of cancer
among persons with inflammatory bowel disease (IBD) and to compare these incidence …

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study

CN Bernstein, JF Blanchard… - Official journal of the …, 2001 - journals.lww.com
OBJECTIVE: The aim of this study was to determine the prevalence of the major extraintestinal
manifestations of inflammatory bowel disease (IBD) and their relation to disease …

The epidemiology of inflammatory bowel disease in Canada: a population-based study

CN Bernstein, A Wajda, LW Svenson… - Official journal of the …, 2006 - journals.lww.com
BACKGROUND Previously, we have demonstrated a high incidence and prevalence of Crohn's
disease (CD) and ulcerative colitis (UC) in the Canadian province of Manitoba. However…

Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study

CN Bernstein, JF Blanchard… - American journal of …, 1999 - academic.oup.com
The aim of this study was to assess the accuracy and utility of administrative health data in
identifying persons with inflammatory bowel disease on a population basis and to determine …